Glyphic Biotechnologies
New York
About Glyphic Biotechnologies
Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform. While DNA can reveal biological insights, proteins provide the actual insights into the functions of our bodies. The company is in the process of developing a pioneering, next-generation protein sequencing platform that will empower researchers to acquire unprecedented insights into both biology and diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $45.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: glyphic.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/glyphic-biotechnologies-39492 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.